BREAKING NEWS Erin McNaught reveals heartbreaking news about her nine month old baby: 'We are absolutely shattered'
Australian model Erin McNaught and her partner Stace Cadet have shared devastating news about their nine-month-old son Obi Brooks Kotaras, revealing he has been diagnosed with a brain tumour.
The couple, who welcomed their first child together in October last year, issued an emotional joint statement on Thursday morning, expressing their anguish over Obi's recent health battle.
'For the last few weeks we have noticed a rapid decline in Obi's behaviour and happiness,' the statement began.
'He was having problems eating, sleeping and most recently, keeping his head straight.'
They explained that after noticing the worrying changes they took Obi in for an MRI scan under the advice of their doctor.
From A-list scandals and red carpet mishaps to exclusive pictures and viral moments, subscribe to the DailyMail's new showbiz newsletter to stay in the loop.
A scan, conducted earlier this week, revealed the shocking diagnosis - a large brain tumour located on the right side of his brain
The scan, conducted earlier this week, revealed the shocking diagnosis - a large brain tumour located on the right side of his brain.
'At about 6:00pm Tuesday night we met with a neurosurgeon who broke the heartbreaking news,' they said.
'We are absolutely shattered and the last few days have been our hardest days.'
The former Miss Universe Australia and her partner went on to praise the team at Queensland Children's Hospital, who are now working with them to determine a treatment plan.
'Our team at the Queensland Children Hospital have been incredible and remain hopeful that we can remove the mass and get Obi healthy and happy pending the results,' they added.
The post has since been flooded with messages of support from family, friends and fans, including Erin's ex-husband Example.
'You got this,' Example wrote, while Steph Claire Smith added: 'Sending healing love ❤️.'
'Heartbreaking, he will pull through, kids are tougher than we realise! Sending thoughts and prayers and absolute positive vibes to you all,' another message read.
This harrowing update follows what was initially a joyful start to parenthood for Erin and Stace, who confirmed the birth of their son exclusively to Daily Mail Australia back in December.
The couple shared at the time that they had named him Obi and were over the moon to bring him home.
'We are so in love with him, we can't believe he's finally here,' Stace said in December. .
'Fair to say we didn't get a lot of sleep when we got home from the hospital last night – mostly because we can't take our eyes off him.'
The former MTV host also previously opened up about her difficult pregnancy, revealing the journey had been 'a little touch and go at times,' with health complications in the final trimester.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
8 hours ago
- Reuters
US FDA puts on hold Rein Therapeutics' lung disease drug trial
June 12 (Reuters) - Rein Therapeutics (RNTX.O), opens new tab has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after the Food and Drug Administration placed a clinical hold, the drug developer said on Thursday. Shares of the company fell nearly 10% after the bell. The company was testing a drug named LTI-03 to treat patients with idiopathic pulmonary fibrosis (IPF). The disease causes scarring of the lungs that makes it harder for them to work properly. Rein said in a filing that it is actively working with the FDA to remove the clinical hold. The FDA and Rein did not immediately respond to Reuters' requests for comment on why the hold was placed. The drug was well-tolerated and safe in an early-stage study in patients with IPF, the company said in the filing. No drug-related serious adverse events have been reported in any studies treating patients with LTI-03, it added. Rein continues to study the drug and enroll patients in Australia and Europe.
Daily Mail
a day ago
- Daily Mail
It is the sunscreen brand singled out by CHOICE as the single WORST failure in Australian SPF 50+ tests. Now the skincare giant furiously hits back
One of the most popular sunscreen brands singled out by a consumer group for failing to meet Australia's strict SPF 50+ regulations has furiously hit back at the controversial experiment. But consumer group CHOICE has revealed it was 'so perturbed' by the results of its extraordinary first experiment - which found Ultra Violette's Lean Screen SPF50+ Mattifying Zinc Skinscreen returned an SPF of just 4 - that it conducted a second test at an independent lab in Germany. CHOICE found that 16 of 20 sunscreens tested in Australia failed to meet the SPF protection claims on its labels, including big brands such as Cancer Council, Neutrogena, Bondi Sands, Coles and Woolworths. Ultra Violette's 'skinscreen', which retails for $52, was called out by CHOICE for having the 'most significant failure' in the entire experiment during the watchdog's first round of rigorous testing. 'We were so perturbed by the results that we decided to delay publishing and test a different batch of the Ultra Violette sunscreen at a completely different lab in Germany to confirm the results,' CHOICE experts said. 'Those results came back with a reported SPF of 5.' Just weeks before the bombshell report dropped, Ultra Violette released a slick social media video showcasing the costly process the business says it undertakes to ensure its products meet SPF requirements - singling out how it spent $150,000 on testing. 'Do you know how SPF is actually tested? Making our SKINSCREENS can cost up to $150,000 in testing alone,' the brand said at the time. 'We take the integrity of our products pretty damn seriously - no cutting corners here. We ensure you have the best protection (from both UVA and UVB), and the added skincare benefits to match, no matter where in the world you are.' The video, narrated by Ultra Violette's co-founder Ava Chandler-Matthews, took viewers behind the scenes of how the company tests its sunscreen products - dwelling on how it cost $150,000 to test them. 'Because we formulate our own products at Ultra Violette, we have to pay for all the testing upfront... It's expensive because you do it on real human skin,' Ava said. She explained that the brand undertake the costly process of SPF testing 'multiple times throughout the product development journey'. 'How it works is they apply a test patch of the sunscreen, then they burn you with a UV lamp, with and without the sunscreen,' Ava said. 'The amount of time it takes for your skin to burn is what determines the SPF, but that's the UVB test. The UVA test is done in a lab. We test to Australian standards first because that's always the hardest. After that, we test to FDA standards. 'All of our sunscreens globally are broad spectrum.' Ultra Violette responds to CHOICE At Ultra Violette we take misleading claims made about our products very seriously. Ultra Violette is deeply committed to the health and safety of our customers and only work with reputable, TGA licensed manufacturers who perform substantial quality release testing in accordance with the strictest SPF standards in the world. Given our commitment to producing the highest quality sunscreens for consumers, we do not accept these results as even remotely accurate. Ultra Violette first completed testing for Lean Screen in 2021 (with results of SPF of 64.32 to allow for an SPF 50+ rating), and again in 2024. However, to ensure complete transparency and peace of mind for our customers, we proactively initiated another urgent SPF test of the batch in question in April this year (2025). We retested our product in a full 10-person panel and the results have come back at 61.7, which is above the threshold required by the TGA to make a 50+ claim. Choice's recent retest only included 5 participants, where 2 results were considered non validated, resulting in a sample size of only 3. We rigorously retest our entire SPF range every two years. Lean Screen has been on the market for 5 years in 29 countries and we have not received a single substantiated claim of sunburn during use – reinforcing our confidence in the testing we have. If the Choice results represented the actual level of protection offered, we would have had hundreds of cases of reported sunburn and skin damage while using this product in real life situations. Read the full Ultra Violette statement and the April 2025 test result here. Ava claimed the brand went the extra mile by doing 'additional' testing on all of their sunscreens because, as she said, 'UVA protection is obviously very important to us'. 'The SPF testing is really just the start. When you own all your own formulations, you have to do stability testing which is to make sure the product is stable and contains the UV actives over time as well as clinical and panel testing,' she said. 'Developing all your own formulations, owning your own sunscreen brand and making that sunscreen brand global is really expensive,' she concluded. Following CHOICE's bombshell report, Ultra Violette disputed the claims, saying: 'Given our commitment to producing the highest quality sunscreens for consumers, we do not accept these results as even remotely accurate. 'Lean Screen contains 22.75 per cent zinc oxide, a level at which, when applied sufficiently, would render a testing result of SPF 4 scientifically impossible.' The brand said Lean Screen, like all UV formulas, are made by reputable, TGA-licensed manufacturers and tested to meet the strictest global SPF standards. 'To ensure complete transparency and peace of mind for our customers, when we were first alerted to CHOICE's testing, we immediately initiated another 10 person test on the batch in question at an independent lab,' an Ultra Violette spokesperson said. 'We proactively initiated another urgent SPF test of the batch in question in April this year (2025). We retested our product and the results have come back at 61.7, which is above the threshold required by the TGA to make a 50+ claim. 'CHOICE's recent retest only included five participants, where two results were considered non validated, resulting in a sample size of only three. 'Over the past four years, we have conducted three different tests at independent labs vs. Choice's 1.3 tests.' The surprising results of the 20 popular sunscreens tested Australian consumer watchdog CHOICE has tested 20 popular sunscreens, with 16 failing to meet the SPF50 protection claims on their labels. Of the 20 sunscreens tested, only four passed the SPF test: Cancer Council Kids Sunscreen SPF 50+ passed with a reported SPF of 52 La Roche-Posay Anthelios Wet Skin Sunscreen 50+ passed with a reported SPF of 72 Mecca Cosmetica To Save Body SPF 50+ Hydrating Sunscreen passed with a reported SPF of 51 Neutrogena Ultra Sheer Body Lotion SPF 50 passed with a reported SPF of 56 Sunscreens that failed the SPF test: SPF results in the 10s Ultra Violette Lean Screen SPF 50+ Mattifying Zinc Skinscreen - tested at 4 SPF results in the 20s Aldi Ombra 50+ – tested at 26 Banana Boat Baby Zinc Sunscreen Lotion SPF 50+ – tested at 28 Bondi Sands SPF 50+ Zinc Mineral Body Lotion – tested at 26 Cancer Council Everyday Value Sunscreen 50 – tested at 27 Cancer Council Ultra Sunscreen 50+ – tested at 24 Neutrogena Sheer Zinc Dry-Touch Lotion SPF 50 – tested at 24 Woolworths Sunscreen Everyday Tube SPF 50+ – tested at 27 SPF results in the 30s Banana Boat Sport Sunscreen Lotion SPF 50+ – tested at 35 Bondi Sands SPF 50+ Fragrance Free Sunscreen – tested at 32 Cancer Council Kids Clear Zinc 50+ – tested at 33 Invisible Zinc Face + Body Mineral Sunscreen SPF 50 – tested at 38 SPF results in the 40s Coles SPF 50+ Sunscreen Ultra Tube – tested at 43 Nivea Sun Kids Ultra Protect and Play Sunscreen Lotion SPF 50+ – tested at 41 Nivea Sun Protect and Moisture Lock SPF 50+ Sunscreen – tested at 40 Sun Bum Premium Moisturising Sunscreen Lotion 50+ – tested at 40
Daily Mail
a day ago
- Daily Mail
BREAKING NEWS Erin McNaught reveals heartbreaking news about her nine month old baby: 'We are absolutely shattered'
Australian model Erin McNaught and her partner Stace Cadet have shared devastating news about their nine-month-old son Obi Brooks Kotaras, revealing he has been diagnosed with a brain tumour. The couple, who welcomed their first child together in October last year, issued an emotional joint statement on Thursday morning, expressing their anguish over Obi's recent health battle. 'For the last few weeks we have noticed a rapid decline in Obi's behaviour and happiness,' the statement began. 'He was having problems eating, sleeping and most recently, keeping his head straight.' They explained that after noticing the worrying changes they took Obi in for an MRI scan under the advice of their doctor. From A-list scandals and red carpet mishaps to exclusive pictures and viral moments, subscribe to the DailyMail's new showbiz newsletter to stay in the loop. A scan, conducted earlier this week, revealed the shocking diagnosis - a large brain tumour located on the right side of his brain The scan, conducted earlier this week, revealed the shocking diagnosis - a large brain tumour located on the right side of his brain. 'At about 6:00pm Tuesday night we met with a neurosurgeon who broke the heartbreaking news,' they said. 'We are absolutely shattered and the last few days have been our hardest days.' The former Miss Universe Australia and her partner went on to praise the team at Queensland Children's Hospital, who are now working with them to determine a treatment plan. 'Our team at the Queensland Children Hospital have been incredible and remain hopeful that we can remove the mass and get Obi healthy and happy pending the results,' they added. The post has since been flooded with messages of support from family, friends and fans, including Erin's ex-husband Example. 'You got this,' Example wrote, while Steph Claire Smith added: 'Sending healing love ❤️.' 'Heartbreaking, he will pull through, kids are tougher than we realise! Sending thoughts and prayers and absolute positive vibes to you all,' another message read. This harrowing update follows what was initially a joyful start to parenthood for Erin and Stace, who confirmed the birth of their son exclusively to Daily Mail Australia back in December. The couple shared at the time that they had named him Obi and were over the moon to bring him home. 'We are so in love with him, we can't believe he's finally here,' Stace said in December. . 'Fair to say we didn't get a lot of sleep when we got home from the hospital last night – mostly because we can't take our eyes off him.' The former MTV host also previously opened up about her difficult pregnancy, revealing the journey had been 'a little touch and go at times,' with health complications in the final trimester.
